| Variables | PI Group (n = 32) | Non-PI Group (n = 126) | Variables | PI Group (n = 32) | Non-PI Group (n = 126) |
| Gender M F |
19 (59.38%) 13 (40.62%) |
52 (41.27%) 74 (58.73%) | Edema No Yes |
19 (59.38%) 13 (40.63%) |
93 (73.81%) 33 (26.19%) |
| Age(years old) 60~ 70 - 79 ≥80 |
12 (37.5%) 11 (34.38%) 9 (28.13%) |
34 (26.98%) 47 (37.30%) 45 (35.71%) | The highest body temperature (˚C) ≥ 37.3 No Yes |
7 (21.88%) 25 (78.13%) |
42 (33.33%) 84 (66.67%) |
| Hospitalization time(d) >1 8~ 15~ 22~ ≥29 |
0 (0%) 4 (12.5%) 6 (18.75%) 4 (12.5%) 18 (56.25%) |
13 (10.32%) 29 (23.02%) 29 (23.02%) 17 (13.49%) 38 (30.16%) | Norton score (points) 13 - 14 points (medium risk) ≤12 points (high risk) |
10 (31.25%) 22 (68.75%) |
69 (54.76%) 57 (45.24%) |
| Main diagnosis CKD5 stage Non-CKD5 stage |
28 (87.5%) 4 (12.5%) |
94 (74.60%) 32 (25.40%)
| Limb mobility Independent Partially dependent Completely dependent |
0 (0%) 10 (31.25%) 22 (68.75%) |
5 (3.97%) 63 (50%) 58 (46.03%) |
| Diabetes No Yes |
10 (31.25%) 22 (68.75%) |
60 (47.62%) 66 (52.38%) | Defecation Controllable Occasionally incontinent Completely incontinent |
7 (21.88%) 11 (34.38%) 14 (43.75%) |
51 (40.48%) 47 (37.30%) 28 (22.22%) |
| Hypertension No Yes |
6 (18.75%) 26 (81.25%) |
22 (17.46%) 104 (82.54%) | Serum albumin ALB (g/L) >35 30~ <30 |
13 (40.63%) 6 (18.75%) 13 (40.63%) |
44 (34.92%) 43 (34.13%) 39 (30.95%) |
| Coronary disease No Yes |
19 (59.38%) 13 (40.63%) |
71 (56.35%) 55 (43.65%) | Hemoglobin HGB (g/L) [14] Normal: >120 (M)/110 (F) Mild: 90 - 120 (M)/110 (F) Moderate: 60 - 90 Severe: 30 - 59 Extremely severe: <30 |
4 (12.5%) 13 (40.63%) 8 (25%) 7 (21.88%) 0 (0%) |
29 (23.02%) 37 (29.37%) 54 (42.86%) 6 (4.76%) 0 (0%) |
| Respiratory infection/respiratory failure No Yes |
8 (25%) 24 (75%) |
74 (58.73%) 52 (41.27%) | |||
| Craniocerebral diseases No Yes |
13 (40.63%) 19 (59.38%) |
77 (61.11%) 49 (38.89%) | Serum creatinine CREA (umol/L) [14] <450 450 - 707 >707 |
18 (56.25%) 9 (28.13%) 5 (15.63%) |
79 (62.70%) 31 (24.60%) 16 (12.70%) |